Uffe Holmskov

Uffe Holmskov

Auto-generated profile, based on publicly available information

Uffe Holmskov

University of Southern Denmark

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 1997 in Nature
Verified
Journal Article
Closed access
STSteffen Thiel
Steffen Thiel
TVThomas Vorup-Jensen
Thomas Vorup-Jensen
Cordula StoverCordula Stover
Cordula Stover
WSWilhelm Schwaeble
Wilhelm Schwaeble
SLSteen B. Laursen
Steen B. Laursen
JJJens C. Jensenius
Jens C. Jensenius

1 April 2003 in Annual Review of Immunology
Verified
Journal Article
Closed access
UHUffe Holmskov
Uffe Holmskov
STSteffen Thiel
Steffen Thiel
JJJens C. Jensenius
Jens C. Jensenius
Collectins and ficolins, present in plasma and on mucosal surfaces, are humoral molecules of the innate immune systems, which recognize pathogen-associated molecular patterns. The human collectins, mannan-binding lectin (MBL) and surfactant protein A and D (SP-A and SP-D), are oligomeric proteins composed of carbohydrate-recognition domains (CRDs) attached to collagenous regions and are thus structurally similar to the ficolins, L-ficolin, M-ficolin, and H-ficolin. However, they make use of different CRD structures: C-type lectin domains for the collectins and fibrinogen-like domains for the ficolins. Upon recognition of the infectious agent, MBL and the ficolins initiate the lectin pathway of complement activation through attached serine proteases (MASPs), whereas SP-A and SP-D rely on other effector mechanisms: direct opsonization, neutralization, and agglutination. This limits the infection and concurrently orchestrates the subsequent adaptive immune response. Deficiencies of the proteins may predispose to infections or other complications, e.g., reperfusion injuries or autoimmune diseases. Structure, function, clinical implications, and phylogeny are reviewed.

1 February 1994 in Immunology Today
Verified
Journal Article
Closed access
UHUffe Holmskov
Uffe Holmskov
RMRajneesh Malhotra
Rajneesh Malhotra
RSRobert Sim
Robert Sim
JJJens C. Jensenius
Jens C. Jensenius

1 June 2000 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
JMJens Madsen
Jens Madsen
AKAnette Kliem
Anette Kliem
ITIda Tornøe
Ida Tornøe
KSKarsten Skjødt
Karsten Skjødt
CKClaus Koch
Claus Koch
UHUffe Holmskov
Uffe Holmskov
Lung surfactant protein-D (SP-D), a collectin mainly produced by alveolar type II cells, initiates the effector mechanisms of innate immunity on binding to microbial carbohydrates. A panel of mRNAs from human tissues was screened for SP-D mRNA by RT-PCR. The lung was the main site of synthesis, but transcripts were readily amplified from trachea, brain, testis, salivary gland, heart, prostate gland, kidney, and pancreas. Minor sites of synthesis were uterus, small intestine, placenta, mammary gland, and stomach. The sequence of SP-D derived from parotid gland mRNA was identical with that of pulmonary SP-D. mAbs were raised against SP-D, and one was used to locate SP-D in cells and tissues by immunohistochemistry. SP-D immunoreactivity was found in alveolar type II cells, Clara cells, on and within alveolar macrophages, in epithelial cells of large and small ducts of the parotid gland, sweat glands, and lachrymal glands, in epithelial cells of the gall bladder and intrahepatic bile ducts, and in exocrine pancreatic ducts. SP-D was also present in epithelial cells of the skin, esophagus, small intestine, and urinary tract, as well as in the collecting ducts of the kidney. SP-D is generally present on mucosal surfaces and not restricted to a subset of cells in the lung. The localization and functions of SP-D indicate that this collectin is the counterpart in the innate immune system of IgA in the adaptive immune system.

1 October 1992 in Clinical and Experimental Immunology
Verified
Journal Article
Open access
PDF file
STSteffen Thiel
Steffen Thiel
UHU. Holmskov
U. Holmskov
LHL. Hviid
L. Hviid
SLS. B. Laursen
S. B. Laursen
JJJ. C. Jensenius
J. C. Jensenius
SUMMARY: Two ELISAs for estimating mannan-binding protein (MBP) were constructed and the concentration of MBP in plasma was followed in patients undergoing major surgery and in patients having a malarial attack. In both cases increases of MBP in the plasma were observed. The relative increase and the kinetics varied from person to person. The concentration of MBP increased between 1·5- and three-fold following surgery. In some patients an increase was seen at day 1 whereas in others the increase was not observed until days 3–9. In the malaria patients an increased level of MBP was maintained during 30 days of treatment with chloroquine. The relative increase in MBP was independent of the presurgery or premalaria levels.

15 November 2010 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
SHSoren Hansen
Soren Hansen
LSLana Selman
Lana Selman
Nades PalaniyarNades Palaniyar
Nades Palaniyar
KZKarel Ziegler
Karel Ziegler
JBJette Brandt
Jette Brandt
UHUffe Holmskov
Uffe Holmskov
Collectins play important roles in the innate immune defense against microorganisms. Recently, a new collectin, collectin 11 (CL-11 or CL-K1), was identified via database searches. In present work, we characterize the structural and functional properties of CL-11. Under nonreducing conditions, in gel permeation chromatography recombinant CL-11 forms disulfide-linked oligomers of 100 and 200 kDa. A mAb-based ELISA estimates the concentration of CL-11 in plasma to be 2.1 μg/ml, and the presence of CL-11 in plasma was further verified by Western blotting and mass spectrometry. Mannan-binding lectin-associated serine protease 1 (MASP-1) copurified with CL-11 and the interaction in plasma with MASP-1 and/or MASP-3 was further demonstrated using ELISA. We identified the adrenal glands, the kidneys, and the liver as primary sites of expression. CL-11 lectin activity was demonstrated by ELISA and showed that CL-11 has preference for l-fucose and d-mannose. We finally show that CL-11 binds to intact bacteria, fungi, and viruses and that CL-11 decreases influenza A virus infectivity and forms complexes with DNA. On the basis of the significant concentration of CL-11 in circulation and CL-11’s interaction with various microorganisms and MASP-1 and/or MASP-3, it is conceivable that CL-11 plays a role in activation of the complement system and in the defense against invading microorganisms.